Copyright
©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 103685
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.103685
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.103685
Figure 1 Effect of erianin on body weight and fasting blood glucose in type 2 diabetes mellitus mice.
A: Body weight; B: Fasting blood glucose. Three independent biological repetitions were used. L: Low; M: Middle; H: High.
- Citation: Chen JH, Dai XC, Quan ZJ, Liu XY. Erianin mitigates diabetic cardiomyopathy via adenosine monophosphate-activated protein kinase-nuclear factor erythroid 2-related factor 2-heme oxygenase-1 pathway activation. World J Diabetes 2025; 16(6): 103685
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/103685.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.103685